Anu Lala

Nov 20, 2024 | healio.com | Erik Swain |Richard Smith |Mikhail Kosiborod |Anu Lala

Potassium binder helps optimize spironolactone use in patients with HF, hyperkalemia risk• A potassium binder enabled more patients with heart failure to stay on spironolactone. • There was a signal of increased risk for HF hospitalization with the potassium binder. CHICAGO — A potassium binder helped patients with HF who have or are at high risk for hyperkalemia stay on spironolactone at an optimal dose, but showed a signal of HF hospitalization risk, researchers reported.

Aug 29, 2023 | healio.com | Regina Schaffer |Richard Smith |Anu Lala

Source/Disclosures Source: Lala A. Unique cardiometabolic risk factors in women across the life span. Presented at: CMHC Women’s Cardiometabolic Health and Wellness Masterclass; Aug. 17-20, 2023; Dana Point, California. Disclosures: Lala reports no relevant financial disclosures. You've successfully added to your alerts. You will receive an email when new content is published. Click Here to Manage Email Alerts We were unable to process your request.